GD2
From Wikipedia, the free encyclopedia
Not to be confused with GD Graphics Library .
GD2 is a disialoganglioside expressed on tumors of neuroectodermal origin, including human neuroblastoma and melanoma, with highly restricted expression on normal tissues, principally to the cerebellum and peripheral nerves in humans.
The relatively tumor specific expression of GD2 makes it a suitable target for immunotherapy with monoclonal antibodies or with artificial T cell receptors.
[edit] See also
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
